Paradigm Biopharmaceuticals Ltd.ASX: PAR

Preclinical study underpins efficacy of Paradigms RhinosulR

Sep 16, 2016 at 3:30 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment